LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62(6):394–399. doi:10.3322/caac.2116123070690
   PubMed Web of Science ®Google Scholar
• Colecchia A, Schiumerini R, Cucchetti A, et al. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol. 2014;20(20):5935–5950. doi:10.3748/wjg.v20.i20.593524876717
   PubMed Web of Science ®Google Scholar
• Rahimi RS, Trotter JF. Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol. 2015;28(3):323–330.26130250
   PubMedGoogle Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.00619239885
   PubMed Web of Science ®Google Scholar
• Tu J, Zhao Z, Xu M, et al. LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14. J Cell Physiol. 2018. doi:10.1002/jcp.27737
   Web of Science ®Google Scholar
• Liu B, Ye B, Yang L, et al. Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. Nat Immunol. 2017;18(5):499–508. doi:10.1038/ni.371228319097
   PubMed Web of Science ®Google Scholar
• Hu Z, Huang P, Yan Y, Zhou Z, Wang J, Wu G. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion. Biochem Biophys Res Commun. 2019;508(1):79–86. doi:10.1016/j.bbrc.2018.11.091
   Web of Science ®Google Scholar
• Xu Y, Zhang G, Zou C, et al. Long noncoding RNA DGCR5 suppresses gastric cancer progression by acting as a competing endogenous RNA of PTEN and BTG1. J Cell Physiol. 2018. doi:10.1002/jcp.27861
   Web of Science ®Google Scholar
• Miao F, Chen J, Shi M, Song Y, Chen Z, Pang L. LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintain cell stemness through the interactions with TGF-beta1. Biosci Rep. 2019;39(1). pii:BSR20181525. doi:10.1042/BSR20181525
   Web of Science ®Google Scholar
• Wu J, Du M, Zhang Q, et al. Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145. Onco Targets Ther. 2018;11:7483–7492. doi:10.2147/OTT.S18229030498361
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi F, Xia Y, Zhao H. LncRNA OIP5-AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer. J Cell Biochem. Epub 2018 Nov 28. doi:10.1002/jcb.28024
   Google Scholar
• Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37(1):289. doi:10.1186/s13046-018-0945-630482236
   PubMedGoogle Scholar
• Wang J, Luo Z, Yao T, Li W, Pu J. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway. J Cell Physiol. 2019;234(5):6908–6916. doi:10.1002/jcp.27449
   Web of Science ®Google Scholar
• Wang Y, Cheng Q, Liu J, Dong M. Leukemia stem cell-released microvesicles promote the survival and migration of myeloid leukemia cells and these effects can be inhibited by MicroRNA34a overexpression. Stem Cells Int. 2016;2016:9313425. doi:10.1155/2016/124365927127521
   PubMed Web of Science ®Google Scholar
• Wang N, Gu Y, Li L, et al. Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Arch Biochem Biophys. 2018;653:63–70. doi:10.1016/j.abb.2018.04.01729702064
   PubMed Web of Science ®Google Scholar
• Xiao Z, Shen J, Zhang L, Li M, Hu W, Cho C. Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: recent progress and future prospects. Oncol Lett. 2018;15(3):3395–3402. doi:10.3892/ol.2018.775829467864
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang S, Liu W. EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database. Biochem Biophys Res Commun. 2018;503(3):1530–1536. doi:10.1016/j.bbrc.2018.07.07530037433
   PubMed Web of Science ®Google Scholar
• Ling ZA, Xiong DD, Meng RM, et al. LncRNA NEAT1 promotes deterioration of hepatocellular carcinoma based on in vitro experiments, data mining, and RT-qPCR analysis. Cell Physiol Biochem. 2018;48(2):540–555. doi:10.1159/00049181130021196
   PubMedGoogle Scholar
• Mo Y, He L, Lai Z, et al. LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2018;37(1):149. doi:10.1186/s13046-018-0831-230001751
   PubMedGoogle Scholar
• Chen W, You J, Zheng Q, Zhu YY. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/beta-catenin signaling pathways. Cancer Manag Res. 2018;10:1817–1826. doi:10.2147/CMAR.S16491129997441
   PubMed Web of Science ®Google Scholar
• Xin X, Wu M, Meng Q, et al. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 2018;17(1):94. doi:10.1186/s12943-018-0843-829895332
   PubMed Web of Science ®Google Scholar
• Zhu P, Wang Y, Wu J, et al. LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun. 2016;7:13608. doi:10.1038/ncomms1360827905400
   PubMed Web of Science ®Google Scholar
• Tu J, Zhao Z, Xu M, Lu X, Chang L, Ji J. NEAT1 upregulates TGF-beta1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p. J Cell Physiol. 2018;233(11):8578–8587. doi:10.1002/jcp.2652429797561
   PubMed Web of Science ®Google Scholar
• Yang T, He X, Chen A, Tan K, Du X. LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. Gene. 2018;670:114–122. doi:10.1016/j.gene.2018.05.06129778425
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang Y, Zhang Y. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-kappaB axis. J Cell Physiol. 2018;233(10):6661–6670. doi:10.1002/jcp.2644629319182
   PubMed Web of Science ®Google Scholar
• Wu X, Yan Y, Li H, et al. DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression. Biochem Biophys Res Commun. 2018;503(3):1247–1253. doi:10.1016/j.bbrc.2018.07.03230029886
   PubMed Web of Science ®Google Scholar
• Wang F, Zu Y, Huang W, Chen H, Xie H, Yang Y. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316. Biochem Biophys Res Commun. 2018;504(1):171–176. doi:10.1016/j.bbrc.2018.08.15030177388
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2018. doi:10.1002/jcp.27744
   Web of Science ®Google Scholar
• Yin Z, Ding H, He E, Chen J, Li M. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell Prolif. 2017;50(1). doi:10.1111/cpr.12368
   Web of Science ®Google Scholar